当前位置:首页 - 行情中心 - 丸美生物(603983) - 财务分析 - 现金流量表

丸美生物

(603983)

  

流通市值:137.54亿  总市值:137.54亿
流通股本:4.01亿   总股本:4.01亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,697,349,069.46898,352,585.353,922,166,113.162,507,857,434.48
  收到的税费返还515.56515.56-50,749.88
  收到其他与经营活动有关的现金58,664,620.9332,046,839.6676,313,507.1550,292,275.88
  经营活动现金流入小计1,756,014,205.95930,399,940.573,998,479,620.312,558,200,460.24
  购买商品、接受劳务支付的现金480,248,306.99254,264,870.41,017,504,988.33821,382,359.36
  支付给职工以及为职工支付的现金152,195,644.6883,750,417.21266,436,208.27195,852,784.32
  支付的各项税费126,308,270.9157,691,416.9267,994,938.88195,300,610.67
  支付其他与经营活动有关的现金918,171,277.36497,499,729.382,172,667,082.511,186,791,466.36
  经营活动现金流出小计1,676,923,499.94893,206,433.893,724,603,217.992,399,327,220.71
  经营活动产生的现金流量净额79,090,706.0137,193,506.68273,876,402.32158,873,239.53
二、投资活动产生的现金流量:
  收回投资收到的现金214,385,978.5457,270,000140,000,000105,000,000
  取得投资收益收到的现金24,541,610.971,002,824.333,771,504.652,884,389.43
  处置固定资产、无形资产和其他长期资产收回的现金净额--24,346.17-
  处置子公司及其他营业单位收到的现金净额110,286.4110,286.4118,918.4-
  收到的其他与投资活动有关的现金--49,527,54049,467,840
  投资活动现金流入小计239,037,875.9158,383,110.73193,442,309.22157,352,229.43
  购建固定资产、无形资产和其他长期资产支付的现金104,342,274.7577,560,025.82205,247,767.2177,169,465.9
  投资支付的现金24,999,854.8424,999,854.84302,130,000147,130,000
  投资活动现金流出小计129,342,129.59102,559,880.66507,377,767.2324,299,465.9
  投资活动产生的现金流量净额109,695,746.32-44,176,769.93-313,935,457.98-166,947,236.47
三、筹资活动产生的现金流量:
  吸收投资收到的现金700,000700,000--
  其中:子公司吸收少数股东投资收到的现金700,000700,000--
  收到其他与筹资活动有关的现金404,794,253.05121,493,293.331,437,822,791.35440,309,091.9
  筹资活动现金流入小计405,494,253.05122,193,293.331,437,822,791.35440,309,091.9
  偿还债务支付的现金--150,000,000150,000,000
  分配股利、利润或偿付利息支付的现金149,009.38-301,341,400.93200,672,175.8
  其中:子公司支付给少数股东的股利、利润--455,984.26-
  支付其他与筹资活动有关的现金398,062,936.19135,979,845.261,584,214,907.56472,434,628.5
  筹资活动现金流出小计398,211,945.57135,979,845.262,035,556,308.49823,106,804.3
  筹资活动产生的现金流量净额7,282,307.48-13,786,551.93-597,733,517.14-382,797,712.4
四、汇率变动对现金及现金等价物的影响-42,086.02-17,794.29-6,647.4925,235.78
五、现金及现金等价物净增加额196,026,673.79-20,787,609.47-637,799,220.29-390,846,473.56
  加:期初现金及现金等价物余额941,260,789.65941,260,789.651,579,060,009.941,579,060,009.94
  期末现金及现金等价物余额1,137,287,463.44920,473,180.18941,260,789.651,188,213,536.38
补充资料:
  净利润156,955,422.13-246,742,825.83-
  资产减值准备2,110,173.95-3,287,597.39-
  固定资产和投资性房地产折旧25,767,363.82-42,043,888.55-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧25,767,363.82-42,043,888.55-
  无形资产摊销7,001,563.96-19,762,865.84-
  长期待摊费用摊销2,498,283.95-973,479.91-
  处置固定资产、无形资产和其他长期资产的损失---377,398.06-
  固定资产报废损失339,798.21-259,847.08-
  公允价值变动损失4,500,110.53--432,554.85-
  财务费用34,506.38-3,808,356.01-
  投资损失-63,967,148.09--27,553,438.99-
  递延所得税-16,130,245.87--16,995,221.31-
  其中:递延所得税资产减少-21,466,720.96--18,982,813.59-
    递延所得税负债增加5,336,475.09-1,987,592.28-
  存货的减少34,645,240.97--16,978,963.04-
  经营性应收项目的减少8,631,245.96-54,365,901.07-
  经营性应付项目的增加-83,493,244.3--36,548,056.92-
  现金的期末余额1,137,287,463.44-941,260,789.65-
  减:现金的期初余额941,260,789.65-1,579,060,009.94-
  现金及现金等价物的净增加额196,026,673.79--637,799,220.29-
公告日期2026-08-292026-04-302026-04-012025-10-31
审计意见(境内)标准无保留意见
TOP↑